Literature DB >> 24146383

Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.

Paul C McDonald1, Shoukat Dedhar.   

Abstract

The development of hypoxic microenvironments within many types of solid tumors imposes a significant stress on cancer cells to which they must respond appropriately in order to survive and grow. Tumor-specific, hypoxia-induced upregulation of Carbonic Anhydrase IX (CAIX) is a component of the complex response of cancer cells to the evolving low oxygen environment. Here, we discuss evidence from in vivo tumor models employing inhibition or enhancement of CAIX expression, using gene depletion or overexpression strategies, respectively, or inhibition of its catalytic activity, using CAIX-specific small molecules or antibodies, to demonstrate that CAIX is a functional mediator of tumor growth and metastasis. We also discuss the functional contribution of CAIX to several specific biological processes critical for cancer progression, including pH regulation and cell survival, adhesion, migration and invasion, the maintenance of cancer stem cell function, and the acquisition of chemo and radioresistant properties. The demonstration of CAIX as a functional mediator of cancer progression provides a biological rationale for its use as a cancer-specific, clinically relevant therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24146383     DOI: 10.1007/978-94-007-7359-2_13

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  23 in total

1.  Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.

Authors:  Caixia Tang; Hu Lei; Jinfu Zhang; Meng Liu; Jin Jin; Hao Luo; Hanzhang Xu; Yingli Wu
Journal:  Cancer Biol Ther       Date:  2018-05-08       Impact factor: 4.742

2.  In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.

Authors:  Srivalleesha Mallidi; Zhiming Mai; Imran Rizvi; Joshua Hempstead; Stephen Arnason; Jonathan Celli; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2015-04       Impact factor: 3.170

3.  Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium.

Authors:  Pankita H Pandya; Amanda J Fisher; Elizabeth A Mickler; Constance J Temm; Kelsey P Lipking; Adam Gracon; Katia Rothhaar; George E Sandusky; Mary Murray; Karen Pollok; Jamie Renbarger; Janice S Blum; Tim Lahm; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

Review 4.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?

Authors:  Jianbo Li; Guojian Zhang; Xuemei Wang; Xiao-Feng Li
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

5.  Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.

Authors:  Hashem O Alsaab; Samaresh Sau; Rami M Alzhrani; Vino T Cheriyan; Lisa A Polin; Ulka Vaishampayan; Arun K Rishi; Arun K Iyer
Journal:  Biomaterials       Date:  2018-08-30       Impact factor: 12.479

6.  Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.

Authors:  Hyungjin Rhee; Ji Hae Nahm; Haeryoung Kim; Gi Hong Choi; Jeong Eun Yoo; Hye Sun Lee; Myoung Ju Koh; Young Nyun Park
Journal:  Mod Pathol       Date:  2016-06-17       Impact factor: 7.842

7.  NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Authors:  Prashant V Bommi; Vaibhav Chand; Nishit K Mukhopadhyay; Pradip Raychaudhuri; Srilata Bagchi
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

8.  Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.

Authors:  Nathaniel H Boyd; Kiera Walker; Joshua Fried; James R Hackney; Paul C McDonald; Gloria A Benavides; Raffaella Spina; Alessandra Audia; Sarah E Scott; Catherine J Landis; Anh Nhat Tran; Mark O Bevensee; Corinne Griguer; Susan Nozell; G Yancey Gillespie; Burt Nabors; Krishna P Bhat; Eli E Bar; Victor Darley-Usmar; Bo Xu; Emily Gordon; Sara J Cooper; Shoukat Dedhar; Anita B Hjelmeland
Journal:  JCI Insight       Date:  2017-12-21

9.  Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX.

Authors:  Pengqin Xu; Yu Zhang; Fanghong Ge; Fuming Zhang; Xia He; Xingya Gao
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

10.  High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7.

Authors:  Aaron R Huber; Dongfeng Tan; Jun Sun; David Dean; Tongtong Wu; Zhongren Zhou
Journal:  BMC Gastroenterol       Date:  2015-07-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.